Listed by the USPTO as SHIN, DANA H
Tech Center 4100 • Art Units: 1635 1638 1674 1682 4100
This examiner grants 27% of resolved cases
SHIN, DANA H has 1174 resolved cases in Tech Center 4100 and Art Unit 1635. The allowance rate is 26.9%, the interview lift is 26.9%, and the median time to allowance is 1218 days. The profile shows a low allowance rate, a positive interview association equal in stated value to that rate, and an extended median prosecution period.
Ionis Pharmaceuticals Inc., The Regents of the University of California, and Northwestern University are the leading listed companies. WOLF GREENFIELD & SACKS, P.C., SUGHRUE MION, PLLC, and Casimir Jones, S.C. are the leading listed firms. The 1174 resolved cases provide substantial data for identifying recurring issues. Practitioners may consider interviews as part of a structured response plan, while the 26.9% allowance rate calls for careful claim strategy and expectation setting.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18065570 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF MICRORNA RELATED DISEASES | Non-Final OA | HOFFMANN-LA ROCHE INC. |
| 19636707 | COMPOSITIONS AND METHODS FOR TREATMENT OF MONOGENIC NEURODEVELOPMENT DISORDERS | Non-Final OA | PYC THERAPEUTICS LIMITED |
| 18592122 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES | Non-Final OA | ModernaTX, Inc. |
| 18024182 | COMPOSITIONS AND METHODS FOR TREATING THERAPY RESISTANT CANCER | Non-Final OA | The General Hospital Corporation |
| 18554771 | GENE THERAPY FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | Non-Final OA | The Regents of the University of California |
| 18271656 | PRIME EDITOR VARIANTS, CONSTRUCTS, AND METHODS FOR ENHANCING PRIME EDITING EFFICIENCY AND PRECISION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18225400 | SPHERICAL NUCLEIC ACIDS WITH DENDRITIC LIGANDS | Final Rejection | NORTHWESTERN UNIVERSITY |
| 17076607 | SPHERICAL NUCLEIC ACIDS WITH DENDRITIC LIGANDS | Final Rejection | NORTHWESTERN UNIVERSITY |
| 17784045 | INDUCTION OF PROLIFEROUS PANCREATIC ISLET PRECURSOR CELL-LIKE CELLS BY TRANSIENT EXPRESSION OF MYCL AND INDUCTION OF DIFFERENTIATION INTO INSULIN-POSITIVE CELLS | Final Rejection | THE UNIVERSITY OF TOKYO |
| 18007560 | RNAI CONSTRUCTS FOR INHIBITING HSD17B13 EXPRESSION AND METHODS OF USE THEREOF | Final Rejection | Amgen Inc. |
| 18063824 | CELLULAR UPTAKE OF FUNCTIONALIZED DNA NANOSTRUCTURES | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18264025 | RIBOSOME-MEDIATED POLYMERIZATION OF NOVEL CHEMISTRIES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18567167 | NANOPARTICLE COMPRISING PEPTIDE-LIPID CONJUGATE FOR DELIVERING OLIGONUCLEOTIDE INTO TARGET CELL AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18495538 | METHODS AND COMPOSITIONS TO REGULATE CHOLESTEROL EFFLUX TO PREVENT, TREAT, OR CURE MACULAR DEGENERATION | Final Rejection | The Trustees of Columbia University in the City of New York |
| 18260748 | SPLICE SWITCHING OLIGONUCLEOTIDES TARGETING PSEUDOEXONS | Non-Final OA | SYDDANSK UNIVERSITET |
| 18057308 | Compositions and Methods for Degradation of Misfolded Proteins | Non-Final OA | The Trustees of the University of Pennsylvania |
| 17837352 | RNA GUIDED ERADICATION OF VARICELLA ZOSTER VIRUS | Non-Final OA | Temple University - of The Commonwealth System of higher Education |
| 18288772 | MULTIPLEX CRISPR/Cas9-MEDIATED TARGET GENE ACTIVATION SYSTEM | Non-Final OA | Salk Institute for Biological Studies |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy26.9% of resolved applications examined by Dana H Shin were allowed (1,174 resolved cases), compared with 51.6% across Art Unit 1635 over the last five years.
This examiner's interview lift is +26.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Dana H Shin took 1,218 days on average from filing to allowance.
Dana H Shin examines applications in Art Unit 1635 in Tech Center 4100.
